Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Carboplatin, Docetaxel, and Radiotherapy in Advanced Endometrial Cancer
NCT00258362Phase 2Completed
- Sponsor
- Masonic Cancer Center
- Start
- Jul 2005
- Primary completion
- Dec 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of docetaxel in endometrial cancer (EC), sponsored by Masonic Cancer Center. Started Jul 2005; status: completed.
02
Drugs
docetaxel
03
Conditions
endometrial cancer (EC)
Beyond the preview
Go deeper on NCT00258362.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00258362.